BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
iShares Global Energy ETF
IXC
$1.85B
| $37.9K | ﹤0.01% |
1,120
-1,455
| -57% | -$49.3K |
|
2802
Medallion Financial
MFIN
$248M
| $37.6K | ﹤0.01% |
5,879
+2,813
| +92% | +$18K |
|
2803
iShares MSCI Global Gold Miners ETF
RING
$2.13B
| $37.6K | ﹤0.01% |
1,726
-430
| -20% | -$9.37K |
|
|
CMLS
2804
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $37.5K | ﹤0.01% |
4,847
+1,293
| +36% | +$10K |
|
2805
CEL-SCI Corp
CVM
$67.7M
| $37.3K | ﹤0.01% |
276
+182
| +194% | +$24.6K |
|
2806
WisdomTree India Earnings Fund ETF
EPI
$2.94B
| $36.5K | ﹤0.01% |
1,229
-129
| -9% | -$3.83K |
|
|
NIU
2807
Niu Technologies
NIU
$321M
| $36.4K | ﹤0.01% |
4,227
-10,470
| -71% | -$90K |
|
2808
Red Violet
RDVT
$676M
| $36.2K | ﹤0.01% |
1,903
+1,885
| +10,472% | +$35.9K |
|
2809
NI Holdings
NODK
$281M
| $36K | ﹤0.01% |
2,194
+1,412
| +181% | +$23.2K |
|
2810
Harvard Bioscience
HBIO
$19.7M
| $35.7K | ﹤0.01% |
9,920
+3,200
| +48% | +$11.5K |
|
2811
TriplePoint Venture Growth BDC
TPVG
$271M
| $35.6K | ﹤0.01% |
+2,794
| New | +$35.6K |
|
|
LFC
2812
DELISTED
China Life Insurance Company Ltd.
LFC
| $35.5K | ﹤0.01% |
4,107
+445
| +12% | +$3.85K |
|
2813
Personalis
PSNL
$541M
| $35.5K | ﹤0.01% |
10,280
-3,681
| -26% | -$12.7K |
|
2814
CytomX Therapeutics
CTMX
$345M
| $35.4K | ﹤0.01% |
19,318
+13,864
| +254% | +$25.4K |
|
2815
Weyco Group
WEYS
$293M
| $35.3K | ﹤0.01% |
+1,445
| New | +$35.3K |
|
2816
Legacy Housing
LEGH
$661M
| $35.3K | ﹤0.01% |
2,703
+1,368
| +102% | +$17.9K |
|
2817
First Guaranty Bancshares
FGBI
$124M
| $34.4K | ﹤0.01% |
+1,417
| New | +$34.4K |
|
2818
The ONE Group
STKS
$82.7M
| $34.4K | ﹤0.01% |
4,670
-5,012
| -52% | -$36.9K |
|
2819
NextDecade
NEXT
$2.01B
| $34.3K | ﹤0.01% |
7,732
+7,135
| +1,195% | +$31.7K |
|
2820
Kartoon Studios
TOON
$38.4M
| $34.2K | ﹤0.01% |
4,524
-275
| -6% | -$2.08K |
|
2821
Target Hospitality
TH
$889M
| $34.1K | ﹤0.01% |
5,966
-6,318
| -51% | -$36.1K |
|
|
ATHX
2822
DELISTED
Athersys, Inc. Common Stock
ATHX
| $33.7K | ﹤0.01% |
5,181
+4,445
| +604% | +$28.9K |
|
|
CONN
2823
DELISTED
Conn's Inc.
CONN
| $33.6K | ﹤0.01% |
4,184
-4,166
| -50% | -$33.4K |
|
2824
Dianthus Therapeutics
DNTH
$1.22B
| $33.4K | ﹤0.01% |
1,740
+1,449
| +498% | +$27.8K |
|
|
SYRS
2825
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $33.3K | ﹤0.01% |
3,461
+2,921
| +541% | +$28.1K |
|